Digital health case studyPharmaceutical

Informing Franchise-Level Resource Allocation Across APAC

Client context: Global biotech, regional innovation team

Strategic question

Which APAC markets should we prioritise for Digital Health investment, and where is our franchise readiness strongest?

Decision enabled

What the client could do next

Enabled franchise leadership to prioritise resource allocation and scouting effort across APAC markets.

Approach

Applying our PlayBook methodology on HealthTech Alpha, we evaluated four APAC markets against user cohorts, therapeutic mix, bio-pharma partnership activity and venture depth, and profiled 10 ventures in detail to validate strategic fit.

Methodology

DefineClarified the strategic question, scope, decision owner and evaluation criteria.

MapIdentified relevant ventures, markets, competitors, partnerships and ecosystem signals.

AssessEvaluated maturity, traction, evidence, strategic fit and operational readiness.

DecideTranslated findings into a decision-ready shortlist, benchmark or recommendation.

Strategic interpretation

Produced a franchise-level view of where Digital Health readiness was real, where it was nascent, and where investment would compound.

Key results

4APAC markets assessed

319Ventures evaluated against criteria

56Prioritised shortlist

Structured digital health intelligence, venture evidence, and analyst interpretation for defensible decisions.

Alpha Brief

Turn this case study into your own decision brief

Answer a few prompts and request a scoped Alpha Brief for your market, portfolio, competitive intelligence, or due diligence question.

Build an Alpha Brief

Request a scoped proposal from this case

Informing Franchise-Level Resource Allocation Across APAC

Which APAC markets should we prioritise for Digital Health investment, and where is our franchise readiness strongest?

What the client could do next

Approach

Methodology

Strategic interpretation

Overview

Category

Stage

Total Funding

GGA Score